| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Dihydromyricetin | Alzheimer's Disease | 7 | PM | 36958211 | 📋 | Dihydromyricetin suppresses inflammatory injury in microglial cells to improve neurological behaviors of Alzheimer's disease mice via the TLR4/MD2 signal |
| Dihydromyricetin | Alzheimer's Disease | 6 | PM | 34932880 | 📋 | Dihydromyricetin Improves Cognitive Impairments in D-galactose-Induced Aging Mice through Regulating Oxidative Stress and Inhibition of Acetylcholinesterase |
| Dihydromyricetin | Alzheimer's Disease | 5 | PM | 33192493 | 📋 | Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer's Diseases |
| Dihydromyricetin | Alzheimer's Disease | 1 | PM | 31797758 | 📋 | Ampelopsin Improves Cognitive Impairment in Alzheimer's Disease and Effects of Inflammatory Cytokines and Oxidative Stress in the Hippocampus |
| Dihydromyricetin | Alzheimer's Disease | 4 | PM | 31596069 | 📋 | Inhibitory Effect of a Flavonoid Dihydromyricetin against Aβ40 Amyloidogenesis and Its Associated Cytotoxicity |
| Dihydromyricetin | Alzheimer's Disease | 3 | PM | 30498091 | 📋 | Protective role of Dihydromyricetin in Alzheimer's disease rat model associated with activating AMPK/SIRT1 signaling pathway |
| Dihydromyricetin | Alzheimer's Disease | 2 | PM | 29869390 | 📋 | Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice |
| Dihydromyricetin | Parkinson's Disease | 5 | PM | 37712262 | 📋 | [Dihydromyricetin alleviates pyroptosis and necroptosis in mice with MPTP-induced chronic Parkinson's disease by inducing autophagy] |
| Dihydromyricetin | Parkinson's Disease | 4 | PM | 36859835 | 📋 | [Dihydromyricetin improves Parkinson's disease-like lesions in T2DM rats by activating AMPK/ULK1 pathway] |
| Dihydromyricetin | Parkinson's Disease | 3 | PM | 32112040 | 📋 | Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin |
| Dihydromyricetin | Parkinson's Disease | 2 | PM | 31223479 | 📋 | Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy |
| Dihydromyricetin | Parkinson's Disease | 1 | PM | 30900456 | 📋 | Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity |
